[
  {
    "ts": null,
    "headline": "Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors despite daily gains",
    "summary": "Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=937d4563fbff91b84e151862400897e2115a77c4a1d46c6412aee14846176fe3",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755017280,
      "headline": "Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors despite daily gains",
      "id": 136337225,
      "image": "",
      "related": "BDX",
      "source": "MarketWatch",
      "summary": "Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=937d4563fbff91b84e151862400897e2115a77c4a1d46c6412aee14846176fe3"
    }
  },
  {
    "ts": null,
    "headline": "[Latest] US Surgical Instrument Tracking Market Size/Share Worth USD 226.61 Million by 2034 at a 11.78% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
    "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Surgical Instrument Tracking Market size & share revenue was valued at approximately USD 74.48 Million in 2024 and is expected to reach USD 83.25 Million in 2025 and is expected to reach around USD 226.61 Million by 2034, at a CAGR of 11.78% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Vizinex (HID Globa",
    "url": "https://finnhub.io/api/news?id=eb5cac009918657375c40123cf6bea4ab02f332230d1e3ef99ffa5aed9f6f7a0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755016200,
      "headline": "[Latest] US Surgical Instrument Tracking Market Size/Share Worth USD 226.61 Million by 2034 at a 11.78% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
      "id": 136320729,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Surgical Instrument Tracking Market size & share revenue was valued at approximately USD 74.48 Million in 2024 and is expected to reach USD 83.25 Million in 2025 and is expected to reach around USD 226.61 Million by 2034, at a CAGR of 11.78% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Vizinex (HID Globa",
      "url": "https://finnhub.io/api/news?id=eb5cac009918657375c40123cf6bea4ab02f332230d1e3ef99ffa5aed9f6f7a0"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why Becton Dickinson (BDX) is a Strong Growth Stock",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finnhub.io/api/news?id=5830d8c70156b4e507b9ece786ec712b3065662b05762bab86c357e506cb5f08",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755006303,
      "headline": "Here's Why Becton Dickinson (BDX) is a Strong Growth Stock",
      "id": 136323177,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=5830d8c70156b4e507b9ece786ec712b3065662b05762bab86c357e506cb5f08"
    }
  },
  {
    "ts": null,
    "headline": "Becton Dickinson Director Acquires 660% More Stock",
    "summary": "Those following along with Becton, Dickinson and Company ( NYSE:BDX ) will no doubt be intrigued by the recent purchase...",
    "url": "https://finnhub.io/api/news?id=919976453733c10a4b3b6de72c33d7a5db6a66c9adc9b1cb36da7a48d5dffe5c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754993525,
      "headline": "Becton Dickinson Director Acquires 660% More Stock",
      "id": 136316339,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Those following along with Becton, Dickinson and Company ( NYSE:BDX ) will no doubt be intrigued by the recent purchase...",
      "url": "https://finnhub.io/api/news?id=919976453733c10a4b3b6de72c33d7a5db6a66c9adc9b1cb36da7a48d5dffe5c"
    }
  },
  {
    "ts": null,
    "headline": "BDX Q3 Deep Dive: Margin Expansion and Portfolio Moves Drive Positive Market Response",
    "summary": "Medical technology company Becton, Dickinson and Company (NYSE:BDX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.9% year on year to $5.51 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $21.85 billion at the midpoint. Its non-GAAP profit of $3.68 per share was 8.2% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=40c5bc7ca8833b5a8ec28724cc379e828e66ea508f1cfb9fd468aa0a03499177",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754983362,
      "headline": "BDX Q3 Deep Dive: Margin Expansion and Portfolio Moves Drive Positive Market Response",
      "id": 136316340,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Medical technology company Becton, Dickinson and Company (NYSE:BDX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.9% year on year to $5.51 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $21.85 billion at the midpoint. Its non-GAAP profit of $3.68 per share was 8.2% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=40c5bc7ca8833b5a8ec28724cc379e828e66ea508f1cfb9fd468aa0a03499177"
    }
  }
]